Method and molecular diagnostic device for detection, analysis and identification of genomic DNA

US9987627B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9987627-B2
Application numberUS-201113073318-A
CountryUS
Kind codeB2
Filing dateMar 28, 2011
Priority dateSep 1, 2005
Publication dateJun 5, 2018
Grant dateJun 5, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

At least one exemplary embodiment of the invention is directed to a molecular diagnostic device that comprises a cartridge configured to eject samples comprising genomic material into a microfluidic chip that comprises an amplification area, a detection area, and a matrix analysis area.

First claim

Opening claim text (preview).

What is claimed is: 1. A microfluidic system comprising: a cartridge configured to isolate genomic material comprising: a reaction chamber; an ejector head; a waste outlet; wherein the reaction chamber is connected to the ejector head and with the waste outlet by a first channel and second channel, respectively; at least one binding and release substrate, wherein the at least one binding and release substrate lies within the reaction chamber and is configured to bind and release at least a portion of a sample comprising genomic material and undesirable material; two electrodes, wherein a first electrode is positioned in the reaction chamber and a second electrode is positioned in the first channel connecting the reaction chamber and the ejector head; and a power source to effect changes in a state of the binding and release substrate; the genomic material releasably bound to the binding and release substrate, wherein the genomic material is released from the at least one binding and release substrate based upon a change in the state of the binding and release substrate; wherein the two electrodes are constructed and arranged to direct charged genomic material into the ejector head while waste material is directed into the waste outlet; and a microfluidic chip, separate from the cartridge, comprising at least one microfluidic inline reaction channel, wherein the genomic material is ejected from the ejector head into an inlet port of the microfluidic chip across an airspace between the cartridge and the microfluidic chip. 2. The microfluidic system according to claim 1 , wherein the at least one binding and release substrate comprises charge switch material. 3. The microfluidic system according to claim 1 , wherein the power source provides an electric voltage to change the state of the at least one binding and release substrate to bind and release at least a portion of the sample is in response to the electric voltage. 4. The microfluidic system according to claim 1 , wherein a fluid received within the reaction chamber has a changeable ionic concentration, wherein the binding and releasing of at least a portion of the sample is in response to a difference in ionic composition of the fluid in contact with the at least one binding and release substrate, and wherein the sample is contained within the fluid. 5. The microfluidic system according to claim 1 , wherein a fluid received within the reaction chamber has a changeable pH, wherein the binding and releasing of at least a portion of the sample is in response to a difference in pH of the fluid in contact with the at least one binding and release substrate, and wherein the sample is contained within the fluid. 6. The microfluidic system according to claim 1 , wherein the at least one binding and release substrate is a particle or bead. 7. The microfluidic system according to claim 1 , wherein the at least one binding and release substrate is magnetic or paramagnetic. 8. The microfluidic system according to claim 1 , wherein the at least one binding and release substrate is bound to the inner surface of the reaction chamber. 9. The microfluidic system according to claim 1 , wherein the cartridge is configured to concentrate the genomic material prior to ejecting the genomic material into the microfluidic chip. 10. The microfluidic system according to claim 1 , wherein the microfluidic chip is configured for performing an amplification reaction.

Assignees

Inventors

Classifications

  • characterised by the means or forces applied to move the fluids · CPC title

  • characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces · CPC title

  • capillary forces · CPC title

  • using electrical currents in the sample itself · CPC title

  • being a microfluidic device · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9987627B2 cover?
At least one exemplary embodiment of the invention is directed to a molecular diagnostic device that comprises a cartridge configured to eject samples comprising genomic material into a microfluidic chip that comprises an amplification area, a detection area, and a matrix analysis area.
Who is the assignee on this patent?
Inoue Hiroshi, Knight Ivor T, Dale Gregory A, and 2 more
What technology area does this patent fall under?
Primary CPC classification B01L3/0268. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).